Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drug therapy. Flecainide.

Literature DB >> 3520324

Drug therapy. Flecainide.

D M Roden, R L Woosley.

Abstract

Entities: Chemical

Mesh：

Substances：

Year: 1986 PMID： 3520324 DOI： 10.1056/NEJM198607033150106

Source DB: PubMed Journal: N Engl J Med ISSN： 0028-4793 Impact factor: 91.245

Keyword Cloud
Cited

× No keyword cloud information.

33 in total

1. The Role of Flecainide in the Management of Catecholaminergic Polymorphic Ventricular Tachycardia.

Authors: Krystien Vv Lieve; Arthur A Wilde; Christian van der Werf
Journal: Arrhythm Electrophysiol Rev Date: 2016-05

2. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.

Authors: Christian van der Werf; Prince J Kannankeril; Frederic Sacher; Andrew D Krahn; Sami Viskin; Antoine Leenhardt; Wataru Shimizu; Naokata Sumitomo; Frank A Fish; Zahurul A Bhuiyan; Albert R Willems; Maurits J van der Veen; Hiroshi Watanabe; Julien Laborderie; Michel Haïssaguerre; Björn C Knollmann; Arthur A M Wilde
Journal: J Am Coll Cardiol Date: 2011-05-31 Impact factor: 24.094

Review 3. Safety of flecainide.

Authors: Juan Tamargo; Alessandro Capucci; Philippe Mabo
Journal: Drug Saf Date: 2012-04-01 Impact factor: 5.606

Drug therapy. Flecainide.

1. The Role of Flecainide in the Management of Catecholaminergic Polymorphic Ventricular Tachycardia.

2. Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia.

Review 3. Safety of flecainide.

4. Flecainide half-life prolongation in 2 patients with congestive heart failure and complex ventricular arrhythmias.

5. Stereoselective disposition of flecainide in relation to the sparteine/debrisoquine metaboliser phenotype.

6. Flecainide toxicity in renal failure.

7. Flecainide: evidence of non-linear kinetics.

8. Beta1-adrenoceptor polymorphism predicts flecainide action in patients with atrial fibrillation.

9. Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency.

10. Electrocardiographic changes in a rare case of flecainide poisoning: a case report.